How effective is Tegretol for Bipolar Affective Disorder? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 3/5
This is a phase IV clinical study of how effective Tegretol (carbamazepine) is for Bipolar affective disorder and for what kind of people. The study is created by eHealthMe from 3 Tegretol users and is updated continuously.
What is Tegretol?
Tegretol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 45,969 Tegretol users. Check the latest studies of Tegretol.
What is Bipolar affective disorder?
Bipolar affective disorder is found to be associated with 17 drugs and 4 conditions by eHealthMe. Check the latest studies of Bipolar affective disorder.
3 people are studied for taking Tegretol in Bipolar affective disorder
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Tegretol effectiveness for Bipolar affective disorder (number of people):
Overall:
- not at all: 0
- somewhat: 1
- moderate: 1
- high: 1
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 0
- very high: 0
Gender of people who take Tegretol for Bipolar affective disorder *:
- female: 0.0 %
- male: 100 %
Age of people who take Tegretol for Bipolar affective disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 33.33 %
- 30-39: 0.0 %
- 40-49: 33.33 %
- 50-59: 33.33 %
- 60+: 0.0 %
Who find Tegretol more effective for Bipolar Affective Disorder?
Gender of people who take Tegretol for Bipolar affective disorder *:
- female: 0.0 %
- male: 100 %
Age of people who take Tegretol for Bipolar affective disorder *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Tegretol?
- You can start a phase IV clinical trial to monitor Tegretol safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Bansal S, Gupta SK, "Sodium Valproate induced priapism in an adult with bipolar affective disorder", Indian journal of pharmacology, 2013 Jan .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Bansal S, Gupta SK, "Sodium Valproate induced priapism in an adult with bipolar affective disorder", Indian journal of pharmacology, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Tegretol (45,969 reports)
Treatments, associated drugs and conditions:
- Bipolar affective disorder (97 reports)
How the study uses the data?
The study is based on carbamazepine (the active ingredients of Tegretol) and Tegretol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ciprofloxacin cause Skin Atrophy? - 5 seconds ago
- Could Temodar cause Haemorrhagic Stroke? - 23 seconds ago
- Could Megestrol Acetate cause Meningioma? - 27 seconds ago
- Could Gemfibrozil cause Aortic Valve Sclerosis? - 33 seconds ago
- Could Biotin cause Chest Injury? - 39 seconds ago
- Could Cyclobenzaprine Hydrochloride cause Nephritis - Interstitial? - 45 seconds ago
- Could Cyclobenzaprine Hydrochloride cause Interstitial Nephritis? - 45 seconds ago
- Drug interactions of Tamsulosin Hydrochloride and Tamsulosin - 50 seconds ago
- Urinary Tract Infection and Iron Deficiency - 59 seconds ago
- Drug interactions of Mesna and Diazepam - a minute ago